Medroxyprogesterone acetate clinical uses
Pro Research Analysisby 
Searched over 200M research papers
Medroxyprogesterone Acetate in Contraception and Reproductive Medicine
Medroxyprogesterone acetate (MPA) is widely used as a hormonal contraceptive, particularly in its depot injectable form (Depo-Provera), which is a highly effective, long-acting, and safe option for birth control. It is especially valued for its convenience as a nondaily method and has a long history of clinical use worldwide. MPA is also associated with some noncontraceptive health benefits, and its safety profile has been well established over decades of use, although patient selection and management of side effects such as changes in menstrual cycle, weight, and mood are important considerations .
MPA for Ovulation Suppression in Assisted Reproduction
MPA is increasingly used in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), to suppress premature ovulation. Studies show that MPA is as effective as gonadotropin-releasing hormone (GnRH) antagonists in preventing premature luteinizing hormone (LH) surges during controlled ovarian hyperstimulation (COH), with similar outcomes in oocyte yield, embryo quality, and pregnancy rates Kuang2015Gilés2023Welp2024+2 MORE. This makes MPA a useful oral alternative for ovulation suppression, offering additional benefits such as lower medication costs, fewer injections, and reduced clinic visits, which can improve patient comfort and convenience Welp2024Gilés2023Gilés2021.
MPA has also been shown to be effective in oocyte donation cycles, with comparable ovarian response and reproductive outcomes to GnRH antagonist protocols, supporting its use as a patient-friendly option in this setting . Furthermore, different dosing regimens of MPA in combination with letrozole for ovarian stimulation have been found to yield similar results in terms of oocyte retrieval, embryo quality, and live birth rates, indicating flexibility in dosing without compromising efficacy .
MPA in Fertility Preservation and Genetic Testing
MPA is a viable alternative to GnRH antagonists for pituitary suppression during ovarian stimulation in elective fertility preservation and preimplantation genetic testing for aneuploidy (PGT-A) cycles. Clinical outcomes, including the number of mature oocytes, embryo quality, and pregnancy rates, are similar between MPA and GnRH antagonist protocols, making MPA a recommended option for these indications as well .
MPA in the Management of Sexual Disorders
MPA has been used in the treatment of male patients with long-standing deviant sexual behavior. Clinical experience indicates that MPA, combined with counseling, can reduce sexual fantasies, arousal, and deviant behaviors, while improving psychosocial functioning. These effects are often maintained after treatment ends, and no permanent physiological changes have been observed, suggesting MPA as a potential treatment of choice in this context .
Drug Interactions and Special Considerations
MPA is metabolized by the cytochrome P450 (CYP3A4) enzyme system, and its effectiveness can be reduced by drug interactions, particularly with certain antiretroviral and antituberculosis medications. These interactions can lead to lower MPA concentrations and risk of contraceptive failure if standard dosing intervals are used. Adjusting the dosing interval to every 8–10 weeks, instead of the standard 12 weeks, can help maintain effective contraceptive levels in women taking these medications .
MPA and Immune Function
There is evidence that MPA can suppress both innate and adaptive immune responses, which may reduce resistance to infections such as HIV-1. MPA has been shown to inhibit the production of key cytokines and chemokines, and to increase HIV-1 replication in immune cells, raising concerns about its use in populations at high risk for HIV infection .
MPA in Hormone Therapy
While MPA is used in hormone therapy for menopausal symptoms, it does not share all the neuroprotective benefits of natural progesterone. Unlike progesterone, MPA does not increase brain-derived neurotrophic factor (BDNF) levels, which may influence its effectiveness in reducing the risk of neurodegenerative diseases .
Conclusion
Medroxyprogesterone acetate is a versatile medication with established clinical uses in contraception, ovulation suppression for assisted reproduction, fertility preservation, and management of sexual disorders. It offers comparable efficacy to other hormonal agents in many reproductive applications, with added benefits of convenience and cost savings. However, clinicians should be aware of potential drug interactions, effects on immune function, and differences from natural progesterone in hormone therapy. Overall, MPA remains a valuable tool in reproductive and sexual health care.
Sources and full results
Most relevant research papers on this topic